MUMBAI, India, Jan. 23 -- Intellectual Property India has published a patent application (202641001505 A) filed by Al-Ameen College Of Pharmacy, Bangalore, Karnataka, on Jan. 6, for 'repurposed loratadine loaded solid lipid nanoparticle dry powder inhaler.'
Inventor(s) include Dr. Tanushree Chakraborty; Dr. Suma R; Mr. Brian Peter Lopez; Dr. Kalpana Devi; Dr. Mubeen Ghani; Mrs. Aisha Khanum; Mr. Rakesh Panda; Mrs. Shithin Ann Varghese; Dr. Vithya Thirumoorthi; and Mrs. Nina Bhagyanath.
The application for the patent was published on Jan. 23, under issue no. 04/2026.
According to the abstract released by the Intellectual Property India: "A system (100) for targeted treatment of non-small cell lung cancer (NSCLC), comprising Loratadine (102) as an active pharmaceutical ingredient; a solid lipid nanoparticle carrier encapsulating the Loratadine (102), wherein the solid lipid nanoparticle comprises Compritol 888 ATO as a solid lipid and Tween 80 as a surfactant; and a dry powder inhaler (104) configured for pulmonary administration of the Loratadine-loaded solid lipid nanoparticles, wherein the solid lipid nanoparticles have a particle size below 200 nm and are configured for deep lung deposition."
Disclaimer: Curated by HT Syndication.
